Drug therapy for smoking cessation: evidence-based considerations for dentistry.
Meta analyses and systematic reviews reported to date provide substantial scientific support for certain forms of pharmacotherapy in smoking cessation. Less information is available on pharmacotherapy for intervention in other forms of tobacco abuse (i.e., spit tobacco). Prior to recommendation or prescription of nicotine replacements and/or prescription of bupropion, the dentist must recognize that drug therapy alone is not appropriate to assist patients in smoking cessation. However, when combined with appropriate behavioral interventions and a demonstrated willingness of the patient to quit tobacco use, drug therapy is a valuable adjunctive service.
Jeske
Arthur H
AH
Department of Restorative Dentistry and Biomaterials, University of Texas Dental Branch, Houston, USA.
Servos
Thomas A
TA
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D016642:Bupropion / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D012907:Smoking / Q000188:drug therapy*; D020340:Tobacco Use Cessation / Q000379:methods*
D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion; D009538:Nicotine